Search results
Results from the WOW.Com Content Network
After sustaining an uptrend on the markets since bottoming in February, GlaxoSmithKline (NYSE:GSK) still has an attractive profile for income and value investors. The stock’s rock-solid dividend ...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...
The stagnating price paired with dividend raises and the prospect of earnings growth has pushed the share's dividend yield up to 3% and the forward price-to-earnings ratio (P/E) down to just 21.5 ...
For premium support please call: 800-290-4726 more ways to reach us
Investors can approximate the average market return by buying an index fund. While individual stocks can be big...
In the latest trading session, GlaxoSmithKline (GSK) closed at $41.54, marking a +1.47% move from the previous day.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
GSK (GSK) closed at $31.85 in the latest trading session, marking a +0.5% move from the prior day. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...